Satellos Bioscience Inc (MSCL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,804 | 19,304 | 38,217 | 32,712 | 40,175 |
| Marketable Securities | 17,906 | 15,310 | 0 | 8,478 | 8,497 |
| Receivables | 370 | 205 | 186 | 338 | 436 |
| TOTAL | $31,884 | $37,497 | $41,112 | $44,365 | $50,873 |
| Non-Current Assets | |||||
| PPE Net | 5 | 6 | 5 | 3 | 3 |
| TOTAL | $5 | $6 | $5 | $3 | $3 |
| Total Assets | $31,889 | $37,503 | $41,117 | $44,368 | $50,876 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,772 | 1,385 | 1,060 | 1,885 | 2,068 |
| Accrued Expenses | 2,261 | 2,004 | 1,615 | 751 | 1,524 |
| TOTAL | $4,105 | $3,503 | $2,770 | $2,699 | $3,592 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4,105 | $3,503 | $2,770 | $2,699 | $3,592 |
| Shareholders' Equity | |||||
| Common Shares | 85,828 | 85,546 | 82,512 | 78,134 | 73,669 |
| Retained earnings | -81,970 | -74,667 | -68,846 | -63,238 | -52,677 |
| Other shareholders' equity | 13,760 | 13,805 | 15,906 | 18,426 | 19,095 |
| TOTAL | $27,784 | $34,000 | $38,347 | $41,669 | $47,284 |
| Total Liabilities And Equity | $31,889 | $37,503 | $41,117 | $44,368 | $50,876 |